Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of an Eye-Movement Intervention on Cognitive Impairment in Individuals Across Illness Stages of Schizophrenia: Protocol for a Stratified Randomized, Active-Controlled, Assessor-Blinded Trial

NCT07702526 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT07702526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07702526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of an Eye-Movement Intervention on Cognitive Impairment in Individuals Across Illness Stages of Schizophrenia: Protocol for a Stratified Randomized, Active-Controlled, Assessor-Blinded Trial
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
July 30, 2028
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high risk for psychosis, cognitive impairment, schizophrenia